The novel elastase inhibitor BAY 85-8501 provides a new approach in the treatment of pulmonary diseases

J. Nagelschmitz, D. Kaufel, S. Stephan, F. von Nussbaum, V. Li, M. Delbeck, K. Lustig, T. Bandel, H. Watz (Wuppertal, Grosshansdorf, Germany)

Source: International Congress 2014 – New drugs for asthma, COPD and pulmonary fibrosis
Session: New drugs for asthma, COPD and pulmonary fibrosis
Session type: Oral Presentation
Number: 3416
Disease area: Airway diseases

Congress or journal article abstract

Rating: 5
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Nagelschmitz, D. Kaufel, S. Stephan, F. von Nussbaum, V. Li, M. Delbeck, K. Lustig, T. Bandel, H. Watz (Wuppertal, Grosshansdorf, Germany). The novel elastase inhibitor BAY 85-8501 provides a new approach in the treatment of pulmonary diseases. Eur Respir J 2014; 44: Suppl. 58, 3416

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: